Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Vildaray M 500mg/50mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Lloyd Healthcare Pvt Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vildaray M 500mg/50mg Tablet SR

Vildaray M 500mg/50mg SR tablets combine two medications to effectively manage elevated blood glucose in patients with type 2 diabetes. This dual action helps mitigate serious diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events like stroke or heart attack. Vildaray M 500mg/50mg SR may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved through consistent medication use, coupled with a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and other medications. Consuming the tablets with meals minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under physician guidance. Maintaining controlled blood sugar levels prevents future complications. Adherence to your doctor's prescribed diet and exercise plan is crucial; lifestyle significantly impacts diabetes management. Common side effects include nausea, diarrhea, vomiting, stomach upset, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential adverse effect, especially when used with insulin or sulfonylureas; appropriate recognition and management strategies are essential. This medication is not universally suitable. Prior to commencing treatment, inform your physician of any history of hepatic, renal, or cardiac disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating women should seek medical counsel before use. Interaction with other medications is possible; provide your doctor with a comprehensive list of all your medications to ensure safety. Alcohol should be limited due to its potential to reduce blood glucose levels. Your doctor will monitor kidney function and blood sugar levels throughout your treatment.

Primary Ingredients of Vildaray M 500mg/50mg Tablet SR

No text was provided to rewrite.

Uses of Vildaray M 500mg/50mg Tablet SR

Managing type 2 diabetes

Major Benefits of Vildaray M 500mg/50mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Vildaray M 500mg/50mg Tablet SR whole; avoid chewing, crushing, or breaking. Administer this medicine with a meal.

Common Side effects of Vildaray M 500mg/50mg Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vildaray M 500mg/50mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Vildaray M 500mg/50mg Tablet SR with a meal.

How Vildaray M 500mg/50mg Tablet SR works:

Extended-release Vildagliptin/Metformin 500mg/50mg tablets (brand name example: Vildaray M) offer a dual-action approach to blood sugar management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Vildaray M 500mg/50mg Tablet SR is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Vildaray M 500mg/50mg tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. Prescribing will depend on a physician's assessment of benefits versus potential risks. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Vildaray M 500mg/50mg tablet is likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Vildaray M 500mg/50mg Tablet SR. Dosage modifications for Vildaray M 500mg/50mg Tablet SR may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

Patients with liver impairment should likely avoid Vildaray M 500mg/50mg SR tablets, as their use may be unsafe. A physician's consultation is recommended.

What if you forget to take Vildaray M 500mg/50mg Tablet SR :

Should you forget a dose of Vildaray M 500mg/50mg Sustained-Release Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vildaray M 500mg/50mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vildaray M 500mg/50mg Tablet SR

Vildaray M 500mg/50mg SR tablets rarely cause hypoglycemia by themselves. However, insufficient caloric intake while using this medication may lead to low blood sugar. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood glucose monitoring is crucial. Always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vildaray M 500mg/50mg Tablet SR. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) require immediate medical attention. Consult your doctor before taking any other medication.
Vildaray M 500mg/50mg Tablet SR is contraindicated in patients with known allergies to its components or excipients. It should also not be used by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Vildaray M 500mg/50mg SR tablets combine metformin (a biguanide) and vildagliptin to manage diabetes. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Vildaray M 500mg/50mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Vildaray M 500mg/50mg Tablet SR and seek immediate medical attention.
Prolonged use of Vildaray M 500mg/50mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Vildaray M 500mg/50mg Tablet SR is safe when used as directed by your doctor. However, even with proper use, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially if taking insulin or sulphonylurea). Report any persistent issues to your doctor.
Vildaray M 500mg/50mg Tab...
125
MRP 145
13% off